aetherAI Annotation-free Whole-slide Training Approach to Pathological Classification Published in Nature Communications
aetherAI’s method for training neural networks on entire whole-slide images (WSIs) using only slide-level diagnoses.
In collaboration with Taipei Medical University Hospital (TMUH), the experiments conducted on a data set of over 9,600 lung cancer WSIs reveal that aetherAI’s proposed method achieves areas under the receiver operating characteristic curve of 0.9594 and 0.9414, respectively, for adenocarcinoma and squamous cell carcinoma classification on the testing set.
“We are excited to see our team’s hard work materialize in a peer-reviewed publication in Nature Communications,” said Joe Yeh, M.D., aetherAI founder and CEO. “The method we propose alleviates the burden of contouring and obtains benefits from scaling up training with numerous WSIs.” Deep learning for digital pathology is hindered by the extremely high spatial resolution of WSIs. Most studies employ patch-based methods, which often require detailed annotation of image patches and typically involve laborious, free-hand contouring on WSIs.
The joint study of aetherAI and TMUH has won the 18th National Innovation Award in 2021, an award created by the Institute for Biotechnology and Medicine Industry (IBMI) in Taiwan which has become the highest honor for biomedical technology corporations and research teams with strong R&D potential.
About aetherAI
Asia’s leading medical image AI solution provider, aetherAI is dedicated to providing cutting-edge solutions for digital pathology transformation, AI-powered diagnostic support systems, and biopharma enterprise services. By leveraging state-of-the-art technologies, aetherAI aims to ease the burden on healthcare professionals and improve diagnostic imaging quality. At the forefront of digital pathology AI, aetherAI partners with top medical centers in the US, Taiwan, and Japan, including UPMC, National Taiwan University Hospital, and Kanazawa University. aetherAI is also a trusted collaborator for such BioPharma companies as Novartis Taiwan and ACT Genomics, and many more are working with us to accelerate AI applications for research efficiency.
Abby Sung
aetherAI CO., LTD.
+886 2 2785 6892
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

